At INTERPHEX 2025, the PharmTech Group spoke with Dave Loula, global product director, ITT Engineered Valves, about innovation in advanced sensing technologies that answer customers' need for reliable valve function.
Editor's note: this interview was previously published on PharmTech.com.
Dave Loula, global product director, ITT Engineered Valves, spoke with the PharmTech Group at INTERPHEX 2025 on customers' need for valves that are easy to maintain and provide consistent performance. The primary focus in valve technology advancements is reliability, particularly in pharmaceutical applications where system integrity and contamination prevention are critical. Key innovations in advanced sensing technologies are those that address this need for reliable and easily maintained valves.
“The advanced sensing—we term this ‘Integrated Sensing Platform,’ our new ISP technology—is part of that reliability solution that the customers are looking for when they're looking for feedback on their valves. They want to make sure that they're getting a reliable sensing of the position of the valve so that they know that a valve is in the open position or in the closed position so they can go on and do their particular operation. The ISP, which is a very small, compact device that fits on top of one of our valves, provides that type of reliable feedback on valve operation,” Loula says.
ISP technology plays a crucial role in maintaining process integrity, reducing the risk of system failures, and ensuring compliance with stringent regulatory requirements. Additionally, the broader platform includes sensors, actuation systems, and advanced monitoring solutions to support end users, original equipment manufacturers, and distributors, Loula explains.
Loula is most looking forward to engaging with industry stakeholders at INTERPHEX to foster collaboration and knowledge exchange. He believes that such engagement ensures that emerging needs in pharmaceutical valve technology are met with cutting-edge solutions.
Click above to view the full interview.
Attendees can visit ITT at Booth #3337 at INTERPHEX 2025, being held in New York City on April 1–3.
Click here for more conference coverage.
David Loula, Global Product Director, ITT Engineered Valves
David Loula has extensive experience in the biopharmaceuticaland industrial sectors, specializing in sales,product management, and business strategy. Currently serving as global product director and previously as global marketing manager at ITT Engineered Valves since August 2012, Loula has driven significant product initiatives and marketing strategies. Prior roles include business development manager at ITT Industries and sales manager at ITT PureFlo, where he managed sales efforts for the Pure-Flo hygienic diaphragm valve product line across a 15-state region. Loula's educational background includes a Bachelor of Science in Mechanical Engineeringdegree from the University of Michigan.
INTERPHEX 2025: Critical Role of Walk-In Chambers in Bio/Pharma Development and Manufacturing
April 3rd 2025Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, sat down with the PharmTech Group at INTERPHEX 2025 to discuss the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.